Langerhans Cell Histiocytosis Associated With Chronic Myeloid Leukemia: A Pediatric Case Report. [PDF]
Latifi A, Yousefian S.
europepmc +1 more source
SHIP-1 adapter functions mediate recruitment of FCRL1 to the BCR and inhibition of ERK. [PDF]
Wolfe MM +3 more
europepmc +1 more source
BCR::ABL1-positive chronic myeloid leukaemia in a scenario of a remote diagnosis of JAK2-V617F-mutated polycythemia vera: a single patient experience with imatinib and ruxolitinib combination therapy. [PDF]
Bartolucci P +7 more
europepmc +1 more source
Under ONIOM Layers: Analysis of BCR-ABL Enzyme Inhibitors Through Bond-Critical Points and Natural Orbitals. [PDF]
Rocha KML, Nascimento ÉCM, Martins JBL.
europepmc +1 more source
Chronic Myeloid Leukemia and the T315I <i>BCR::ABL1</i> Mutation. [PDF]
Pierro F +8 more
europepmc +1 more source
Kinase inhibition rewires the HLA-I immunopeptidome in chronic myeloid leukemia. [PDF]
Venafra V +10 more
europepmc +1 more source
Sequential occurrence of BCR::ABL1-negative MPN and CML and vice versa: results from a real world cohort. [PDF]
Schweneker K +6 more
europepmc +1 more source
Hypoxic conditions confer chemoresistance to crizotinib but not to imatinib in chronic myeloid leukemia cells. [PDF]
Avinery L +4 more
europepmc +1 more source
Potential signaling pathways, biomarkers, natural drugs, and chronic myeloid leukemia therapeutics. [PDF]
Alqahtani S.
europepmc +1 more source
Rare Atypical Ela3 BCR-ABL transcript in acute Lymphoblastic Leukemia: a case report. [PDF]
Xu L, Han T, Wei S, Wang N.
europepmc +1 more source

